The evolution of computation-driven paradigms in targeted peptide drug design: From predictive modeling to generative AI and clinical translation
A strategic roadmap for seamlessly integrating generative AI with physics-based validation with physics-based validation is provided, thereby accelerating the transition of computationally designed peptides from in silico blueprints to viable clinical candidates.